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Abstract
Avian influenza virus (AIV) subtypes H5 and H7 can infect poultry causing low pathogenicity
(LP) AI, but these LPAIVs may mutate to highly pathogenic AIV in chickens or turkeys caus-
ing high mortality, hence H5/H7 subtypes demand statutory intervention. Serological surveil-
lance in the European Union provides evidence of H5/H7 AIV exposure in apparently healthy
poultry. To identify the most sensitive screening method as the first step in an algorithm to
provide evidence of H5/H7 AIV infection, the standard approach of H5/H7 antibody testing
by haemagglutination inhibition (HI) was compared with an ELISA, which detects antibodies
to all subtypes. Sera (n = 1055) from 74 commercial chicken flocks were tested by both meth-
ods. A Bayesian approach served to estimate diagnostic test sensitivities and specificities, with-
out assuming any ‘gold standard’. Sensitivity and specificity of the ELISA was 97% and 99.8%,
and for H5/H7 HI 43% and 99.8%, respectively, although H5/H7 HI sensitivity varied con-
siderably between infected flocks. ELISA therefore provides superior sensitivity for the screen-
ing of chicken flocks as part of an algorithm, which subsequently utilises H5/H7 HI to identify
infection by these two subtypes. With the calculated sensitivity and specificity, testing nine
sera per flock is sufficient to detect a flock seroprevalence of 30% with 95% probability.
Introduction
Avian influenza virus (AIV) subtyping is based on their haemagglutinin (HA) and neuramin-
idase (NA) envelope glycoproteins, with currently 16 antigenically different HA (H1–H16)
and nine NA (N1–N9) subtypes [1]. Most commonly, AIV introductions from wild birds
into poultry result in few (if any) obvious clinical signs, and are termed low pathogenicity
(LP)AI [2]. However, H5 and H7 AIV subtypes have the potential to mutate to highly patho-
genic (HP) AIVs in Galliforme poultry such as chickens and turkeys, resulting in high
mortality [3]. Consequently, all H5 and H7 AIV poultry incursions require statutory interven-
tions to prevent spread and control outbreaks [4–6], with H5 and H7 AIVs of both pathotypes
considered as notifiable pathogens [7]. In addition, H5 and H7 influenza A viruses include
H5N1 HPAIV and H7N9 LPAIV as proven zoonotic pathogens [8].
The presence of clinical signs in Galliformes enabled HPAI to be detected early inmost recent
instances in Europe, through passive surveillance [9]. Many H5/H7 LPAI outbreaks [10, 11] ori-
ginate via LPAIV incursion into poultry fromwild birds and then present a risk for evolution into
the HP phenotype [1]. Because LPAIV infections in poultry normally proceed sub-clinically or
with minor signs [12], serological monitoring for H5/H7 AIVs is indicated [13]. There are pre-
cedents of prolonged H5/H7 LPAIV dissemination, some of which include subsequent mutation
to the corresponding HPAIV [14–16]. Extensive H7N1 LPAIV spread in Italy during 1999 pre-
ceded an extensive H7N1 HPAIV outbreak, and contributed to the introduction of mandatory
European Union (EU) poultry surveillance [13], with the presence of H5/H7 subtype-specific
antibodies identifying flocks infected with these AIV subtypes. The flocks are then investigated
further for possible ongoing infection [13]. National poultry surveillance aims to reduce the risk
of subsequent HPAI emergence, and provides an epidemiological indication of whether H5/H7
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subtypes may be circulating in a particular sector of the EU poultry
industry. Freedom from infection is also important to facilitate
trade [4]. A range of diverse poultry production practices with per-
ceived risks of H5/H7 AIV incursions is considered in different EU
countries. These differences influence the extent of flock sampling
in national surveillance programmes [17]. The results are published
annually [18, 19].
From the laboratory perspective of carrying-out poultry sur-
veillance, the haemagglutination inhibition (HI) test is a well-
established assay that has the advantage of detecting haemagglu-
tinin (HA) type-specific antibodies [20]. Therefore, H5 and H7
HI testing is recommended for the identification of past infection
with these subtypes [7, 21]. Whole virus, live or inactivated, is
used as antigen for the HI test. The EU testing algorithm recom-
mends defined H5 and H7 viruses as the primary broadly reactive
HI antigens for the screening of H5 and H7 antibodies [13]. Sera
from flocks that are positive in the primary H5/H7 HI test are
then retested by using other H5 or H7 antigens with a different
NA subtype, these being the defined secondary HI antigens.
Confirmation of H5/H7 infection by HI with the corresponding
secondary antigen is important to exclude the possibility that
the primary HI-positive result was influenced by cross-reactivity
with the NA subtype [22]. The EU-recommended primary and
secondary H5 and H7 HI antigens have broad overlapping sero-
logical reactivity to contemporary H5 and H7 AIVs circulating
in Europe. All H5/H7 confirmed serological findings must be
followed-up by testing additional sera and swabs collected from
the poultry [13]. Testing of the former may reveal increasing sero-
conversion in instances of a very recent incursion, while testing of
the latter by virus isolation (VI) or AIV reverse transcription Real
Time (RRT)–PCR may confirm or exclude ongoing virus circula-
tion at the premises [23].
This study assessed an alternative approach using a commer-
cial blocking ELISA for the initial screening of poultry. This
assay detects antibodies directed against the conserved nucleopro-
tein (NP), thereby detecting humoral responses to all AIV sub-
types [7]. To identify evidence of H5/H7 LPAIV infection, all
ELISA-positive sera were subsequently tested in the HI test by
using both primary H5 and H7 antigens. Sera that return a posi-
tive result with the initial HI test with either primary H5 or H7
antigens are then retested using secondary H5 or H7 antigen to
confirm past H5/H7 AIV infection [13]. To evaluate the suitabil-
ity of this new testing algorithm to identify H5/H7 infection, the
sensitivity and specificity of both the ELISA and the primary
H5/H7 HI tests were determined and compared. While HI is a
long-established test for the detection of HA subtype-specific
antibody, which continues to be recommended, it cannot be
uncritically assumed to represent a ‘gold standard’, particularly
when the current OIE test validation guidelines are considered
[24]. It is imperative that the screening approach has a proven
high sensitivity to prevent false negative results. This study deter-
mined the sensitivity and specificity of the two screening methods
by means of Bayesian mathematical modelling which, import-
antly, does not presuppose that either ELISA or primary H5/H7
HI is a ‘gold standard’ to which the other is compared.
Methods
Sera
Chicken sera (1055) from 74 commercial farms were tested in this
study. All were sourced from a subset collected for the national
poultry surveillance programmes in four EU Member States
(MSs) (namely Denmark, Sweden, UK and The Netherlands)
during the years 2009 (one flock in Denmark, 39 sera) and
2012–2013 for the remaining 73 flocks in Sweden (40 sera, four
flocks), the UK (245 sera, 17 flocks), The Netherlands (284
sera, 11 flocks) and Denmark (447 sera, 41 flocks) (Table 1).
The 17 UK chicken flocks, all AIV seronegative, were selected ran-
domly during national poultry surveillance, as were 40 of the 42
Danish flocks, four of which were seropositive for non-H5/H7
AIV. However, non-random inclusion of H5/H7 and non-H5/
H7 seropositive flocks was required to provide sufficient data
for the Bayesian model. Two additional Danish flocks were there-
fore deliberately included to provide H5- and H7-positive sera
(Table 2). The intense AI poultry surveillance in The
Netherlands also provided 11 of the 21 AIV seropositive chicken
flocks in this study (Tables 1 and 2). Therefore The Netherlands
flocks were also not selected randomly. The 11 H5/H7 seroposi-
tive flocks identified in Denmark and The Netherlands provided
the majority of the chicken sera, which were positive by either the
primary H5/H7 HI and/or ELISA (n = 282; Table 2). Sera from
these 11 flocks were critical to enabling the model to determine
the sensitivity and specificity of screening for H5/H7. Secondary
HI testing confirmed all 11 H5/H7 seropositive flocks. The four
Swedish flocks which were seropositive for non-H5/H7 were
also selected non-randomly (Table 2). The non-random selection
of chicken flocks was factored into the Bayesian model.
Table 1. Description of the 74 chicken flocks and flock-level serology results
Country Layers
Outdoor
layers
Organic
layers Broilers Breeders
Total flocks
sampled per
country
Total
sera
AI
positive
flocks
H5/H7-
positive
flocks
The Netherlands 7 4 11 284 11 9
Denmark 6 7 19 5 5 42 486 6 2
Sweden 2 1 1 4 40 4 0
UK 14 3 17 245 0 0
Totals 20 14 25 6 9 74 1055 21 11
Total numbers of chicken flocks and sera tested by primary H5/H7 HI and ELISA in each of the four countries. At the flock-level, flocks are categorised as either AI or H5/H7 positive. EU
definitions of free-range poultry as either ‘outdoor’ or ‘organic’ are summarised at: http://www.britishpoultry.org.uk/introduction-to-marketing-standards-for-free-range-and-organic-poultry-
meat/ (Accessed 13 October 2017).
The six Danish layer flocks consisted of one caged-layer flock and five layer-breeder flocks. The breeder flocks from Denmark (n = 5) and Sweden (n = 1) were all broilers. Further details were
unavailable for the UK outdoor layer (n = 14) and breeder (n = 3) flocks.
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HI antigen preparation
Four HI viral antigens of the H5 and H7 subtypes were grown for
surveillance purposes in 9–11-day-old embryonated fowls’ eggs at
the Animal and Plant Health Agency (APHA, UK) using stand-
ard protocols [7, 21]. Allantoic fluid harvests were inactivated
by adding neat beta-propiolactone (Ferak, Berlin, Germany) as
a 1 : 2000 dilution which produced an 8 mM final strength solu-
tion. The mixture was incubated for 16 h at 37 °C with stirring.
One ml volumes of allantoic fluid were freeze-dried and distribu-
ted to the participating laboratories, for reconstitution in 1 ml
sterile distilled water. The primary H5 and H7 HI antigens were
A/teal/England/7394-2805/06 (H5N3) and A/turkey/England/
647/77 (H7N7), respectively, while the secondary HI antigens
were A/chicken/Scotland/59 (H5N1) and A/African starling/
England/983/79 (H7N1) [13].
Serological testing
The chicken sera collected from a given MS were tested at the
respective AI National Reference Laboratory (NRL). All sera
were tested by the multi-species influenza A ELISA (IDEXX,
France) according to the manufacturer’s instructions. This block-
ing ELISA detects antibodies against the influenza A NP antigen,
which is common to all subtypes. All sera were also tested by HI
using the primary H5 and H7 antigens by using four HA units
per test and a cut-off where a serum dilution titre of 1 : 16 or
greater was considered positive [7, 13, 21]. All sera from flocks
which registered positive primary HI reactivity in at least one
serum were retested by the corresponding secondary H5 or H7
HI antigens to confirm seropositivity for H5/H7. The H5/H7
HI testing was restricted to the use of the surveillance (heterol-
ogous) antigens, which reflected normal practice during the EU
Table 2. Serology results from the 21 AI-positive flocks from The Netherlands, Denmark and Sweden
Flock identity number
and HA subtype
Type of
chicken flock
ELISA result/primary HI result
Total sera
tested per flock
Observed AI seroprevalence
per flock
Pos/Pos Pos/Neg Neg/Pos Neg/Neg ELISA (%)
Primary
HI (%)
The Netherlands
1 H7 Organic layer 4 6 0 8 18 55.6 22.2
2 H5 Outdoor layer 3 13 0 9 25 64 12
3 H5 Outdoor layer 13 8 1 16 38 55.3 36.8
4 H7 Outdoor layer 7 7 0 15 29 48.3 24.1
5 H5 Outdoor layer 2 19 0 9 30 70 6.7
6 H7* Organic layer 16 6 0 8 30 73.3 53.3
7 H7 Outdoor layer 15 3 0 0 18 100 83.3
8 H6* Organic layer 0 15 0 15 30 50 0
9 H5 Organic layer 2 19 0 8 29 72.4 6.9
10 Non-H5/H7 Outdoor layer 0 16 0 14 30 53.3 0
11 H5 Outdoor layer 1 6 0 0 7 100 14.9
Denmark
12 Non-H5/H7 Outdoor layer 0 1 0 9 10 10 0
13 Non-H5/H7 Organic layer 0 1 0 9 10 10 0
14 Non-H5/H7 Organic layer 0 9 0 1 10 90 0
15 Non-H5/H7 Organic layer 0 9 0 1 10 90 0
16 H7 Organic layer 10 28 0 1 39 97.4 25.6
17 H5 Outdoor layer 15 2 1 1 19 89.5 84.2
Sweden
18 Non-H5/H7 Organic layer 0 9 0 1 10 90 0
19 Non-H5/H7 Organic layer 0 1 0 9 10 10 0
20 Non-H5/H7 Broiler 0 3 0 7 10 30 0
21 Non-H5/H7 Broiler-breeder 0 1 0 9 10 10 0
Total sera 88 182 2 150 422
All sera were tested by both ELISA and primary H5/H7 HI. The four central columns indicating the four results categories present the data which were analysed by the Bayesian model. All H5
and H7 seropositive flocks were confirmed by testing with the corresponding secondary HI antigen. * Indicates H7N7 LPAIV isolation from flock 6 in The Netherlands, while H6 seropositive
flock 8 was identified by additional HI testing with non-H5/H7 antigens (data not shown).
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national poultry surveillance programmes [13]. One flock in The
Netherlands was identified as having been actively infected with
an H7N7 LPAIV at the time of serological sampling of chickens
(Table 2), but no H7 HI testing was done with the homologous
H7 LPAIV isolated from this flock. All four AI NRLs involved
in this study participate in annual HI proficiency testing to
demonstrate their mandatory test competence [25].
Statistical methods
A Bayesian method was employed to estimate the sensitivity and
specificity of the ELISA and primary H5/H7 HI tests, and the true
within-flock seroprevalence. Bayesian methods have been shown
to be highly useful for diagnostic test evaluation in the absence
of a gold standard [26, 27]. The key feature of a Bayesian method
is that prior assumptions for all the unknown parameters are
combined with maximum-likelihood inference on the available
data to provide final (posterior) estimates, which are a weighted
average of the prior assumptions and inference from the data.
In the present study, we chose to have non-informative priors
for the test sensitivities, specificities and within-flock prevalence
(beta distributions with both parameters equal to 1, which are
uniform in the range 0–1) so that the final outputs were totally
driven by the study data. The design of the Bayesian model
assumed that the sensitivity of the primary H5 and primary H7
HI tests was the same. The analysis considers both primary
H5/H7 HI tests as a screening test which, when followed by sec-
ondary HI testing, leads towards the identification and confirm-
ation of past H5/H7 infection. The model was not based on
random testing of flocks in all of the countries, but was designed
to analyse input data consisting of the numbers of sera belonging
to each of four categories of test results in each flock. These were
the number of results which were: (1) positive by both ELISA and
primary HI, (2) positive by ELISA but negative by primary HI, (3)
negative by ELISA but positive by primary HI and (4) negative by
both tests (Table 2).
Let the within-flock seroprevalence of H5/H7 be denoted by π.
For the data from The Netherlands, intensive efforts were made to
establish the strain type, and there was no evidence of multiple
strains infecting any of the flocks. In addition, the generally
good standards of biosecurity practiced by the commercial
poultry sector in Europe and history of results from recent
years’ EU poultry surveillance [18, 19] allowed the assumption
to be made that the chickens had been exposed to only one strain
of AIV, i.e. we assumed that the chickens will not have been
infected by both H5/H7 and non-H5/H7 AIVs. The sensitivity
and specificity of the primary HI to detect H5/H7 AI are denoted
by SeH, SpH, and the sensitivity and specificity of the ELISA to
detect avian influenza of any subtype is denoted as SeE, SpE. We
assumed that there was no difference in the sensitivity and speci-
ficity of ELISA according to the subtype, so that it would detect
H5/H7 and non-H5/H7 antibodies with the same likelihood.
Flocks that were positive only for ELISA were excluded from
the Bayesian model, since these flocks provided no information
on the sensitivity of primary H5/H7 HI, and it would also require
a more complex model to incorporate this data into the model for
the little extra benefit. However, the seroprevalence was estimated
for these flocks by taking into account the sensitivity and specifi-
city of ELISA estimated from the HI and ELISA-positive flocks,
and the flocks which were negative for both HI and ELISA.
With these assumptions, the likelihood of both primary HI
and ELISA testing positive on a serum sample from any bird
within a flock is given by the sum of (i) the probability that
the bird had antibodies to H5/H7 AIV and correctly identified
by both tests, πSeHSeE, and (ii) the probability that the bird did
not have antibodies to H5/H7 AIV and was incorrectly classified
by both tests (1− π)(1− SpH)(1− SpE). Similar reasoning can
be applied to derive the probabilities for the other test outcomes.
Denoting by pij, i, j = 0, 1 the likelihood that primary HI or ELISA
was negative (i,j = 0, respectively) or positive (i,j = 1), respectively,
the other test outcomes had the following probability:
p00 = (1− SeH)(1− SeE)p+ SpHSpE(1− p),
p01 = (1− SeH)SeEp+ SpH(1− SpE)(1− p),
p10 = SeH(1− SeE)p+ (1− SpH)SpE(1− p).
The outcome for each bird in each flock arises from a multi-
nomial distribution with the probability of each of the four pos-
sible outcomes given bypij. The basic idea aim of the study is to
apply statistical approaches to find the values of the sensitivity
and specificity of each test and the within-flock prevalence that
produces the best fit to the observed data, i.e. effectively solving
equations p00, p01, p10, p11 for each flock using a Bayesian
approach. The multinomial model was fitted to the data from
each flock using WinBUGS 3.1. The approach works by having
initial starting values, which converge towards the final (poster-
ior) estimates and so the first 5000 iterations were discarded as
a burn-in period before convergence had been reached. After
the burn-in period, 10 000 iterations were used to generate the
final (posterior) estimates, and convergence assessed using the
Gelman–Rubin statistic, as implemented in WinBUGS.
The fit of each model to the data was assessed by the use of
Bayesian P-values, which are a measure of model fit based on
Pearson’s chi-squared statistics [28], where a low P-value repre-
sents a poor fit of the model to the data. The WinBUGS code
for the model was adapted from a previously supplied code [29].
Calculation of sample sizes for screening
The number of serum samples required to detect exposure to
H5/H7 AIV using primary HI or ELISA at the initial screening
was calculated according to the following formula, based on the
formula for sampling large flocks/herds [30]:
Ni(p) = log (1− t)log (1− hi(p))
,
where τ is the required statistical power. For the estimate of the
sensitivity of the method given the within-flock prevalence
(ηi(π)), the median estimate of the Bayesian posterior was used.
Sample sizes were estimated for each sample type for the detection
of the following within-flock infection seroprevalences: 2.5%, 5%,
10%, 20%, 30%, 40% and 50%.
Results
Serological results from commercial chickens
All 245 sera collected from 17 chicken flocks in the UK were nega-
tive by both the ELISA and both primary HI antigens (Table 1).
The remaining 57 flocks tested in the three other countries
included 21 AI seropositive flocks. Among these, there were six
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flocks seropositive for H5 and five seropositive for H7. Nine of
these seropositive flocks occurred in The Netherlands and two
in Denmark (Tables 1 and 2). The 11 H5/H7 seropositive flocks
were confirmed by retesting with the corresponding H5 or H7
secondary HI antigen (data not shown). In The Netherlands,
H7N7 LPAIV was successfully isolated from one H7 seropositive
flock to indicate active ongoing infection, while one non-H5/H7
infected flock was characterised as being H6 seropositive by
additional testing (Table 2).
Estimation of test sensitivity and specificity by applying the
Bayesian model
Within the 11 H5/H7-positive flocks, there were 205 sera that
were ELISA positive and 90 that were primary H5/H7 HI-positive
sera. Two sera were negative by ELISA and positive by primary HI
compared with 117 sera that were positive for ELISA and negative
by primary HI (Table 2). Consequently, the model estimates of
ELISA sensitivity (97%) are much higher than that of primary
HI (43%, Table 3). High specificity (>99%) was determined for
both primary HI and ELISA (Table 3).
While there was no evidence of an unsatisfactory fit to the
model overall, with a Bayesian P-value of 0.11 for the model fit
to the dataset as a whole, there was an apparent large variability
in the sensitivity of the primary HI between flocks. For example,
in flocks 5 and 9, the model significantly overestimates the num-
ber of HI positives, suggesting a much lower sensitivity than 43%
for primary HI in those flocks (also evidenced by the lower rela-
tive sensitivity of HI to ELISA: 2/21 (9.5%) observed in both
flocks; Fig. 1). In flocks 7 and 17, the model greatly underesti-
mates the number of HI positives, suggesting a much higher
sensitivity in those flocks (relative sensitivity of HI to ELISA
15/18 (83.3%) and 15/17 (88.2%) observed in flocks 7 and 17,
respectively; Fig. 1).
Sample size estimation
Because of the lower sensitivity of the primary HI test compared
with the ELISA, much larger sample sizes were required when
using the HI test, compared with the ELISA, to achieve the
same level of confidence in determining a flock’s status. Using
the ELISA, a sample size of nine sera is sufficient to provide
95% confidence of detecting H5/H7 infection in a flock when
the seroprevalence exceeds 30%, whereas a sample size of 22 is
necessary to achieve the same level of confidence when using
HI (Table 4).
Within-flock seroprevalence
The model was able to estimate the seroprevalences in the 21
AIV-infected chicken flocks (Fig. 2), which showed that within-
flock prevalence was <50% for the majority of flocks in the study.
Discussion
The key outcome is that ELISA detection of influenza A antibody
is a reliable method for serological screening to seek evidence of
H5/H7 LPAIV infection in chicken flocks, with high sensitivity
(97.0%) and specificity (99.8%) clearly apparent (Table 3).
Screening by primary H5/H7 HI was also highly specific
(99.8%), but sensitivity was much lower (43.0%) (Table 3). The
two tests differ in detecting antibody responses to different AIV
antigens, namely HA and NP, which demonstrate (past) infection
by H5/H7 LPAIVs and those caused by all AIV subtypes, respect-
ively. This difference between the tests was considered in the
design of the Bayesian model which compared the two tests as
the screening step towards identifying H5/H7 AIV infection.
The sensitivity and specificity findings show that a surveillance
algorithm based on initial screening by the pan-subtype ELISA
followed by the H5/H7 HI testing using the heterologous antigens
is a potentially preferable approach to identify evidence for
H5/H7 AIV infection.
The manufacturer of the ELISA quotes similar high sensitivity
(95.4%) and specificity (99.3%) respectively (http://www.idexx.co.
uk/pdf/en_gb/livestock-poultry/influenza-a-ab-test-sheet.pdf), but
these were derived by a traditional approach where the ELISA was
compared relative to an incompletely defined ‘AI serological sta-
tus’ in avians which served as a ‘gold standard’. The HI test has
been long used to measure type-specific humoral responses to
natural influenza A virus infection and vaccination, before the
emergence of ELISA technology [31]. HI is recommended for
poultry surveillance through detection of H5- and H7-specific
antibodies [13]. The availability of commercial ELISAs for generic
AIV antibody detection has been noted by the OIE, but without
any recommendations regarding their use in surveillance [7].
An important aspect of this study was that Bayesian modelling
was not dependent on either of the tests being assumed to be a
Table 3. Sensitivity and specificity estimates (Bayesian) of the ELISA and
primary H5/H7 HI tests
Parameter Description
Bayesian estimates
Median
2.5 and 97.5
percentiles
SeH Sensitivity of HI 0.43 (0.36, 0.50)
SpH Specificity of HI 0.998 (0.994, 1.0)
SeE Sensitivity of ELISA 0.97 (0.94, 0.99)
SpE Specificity of ELISA 0.998 (0.993, 1.0)
Fig. 1. The fit of the Bayesian model (black bars) to the observed data (white bars)
for each of 11 H5/H7 AI-positive flocks tested with both ELISA and primary H5/H7 HI
in The Netherlands and Denmark. The 11 flock identifiers correspond to those listed
in Table 2.
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‘gold standard’, and can robustly estimate the uncertainty in each
of the test characteristics (Table 3), which would be more prob-
lematic when making such an assumption. This approach is
now accepted by the OIE as a valid means of determining test sen-
sitivity and specificity [24].
There was some non-random selection of flocks in order to
increase the numbers of H7/H7-positive chickens. If there was a
bias caused through a selection of known H5/H7 positives, then
it would be more likely to affect the sensitivity estimates; the spe-
cificity is largely determined by the 53 negative flocks from the
UK and Denmark which were selected randomly.
An advantage of the HI test is that it requires reagents, which
are relatively inexpensive to produce by international AI reference
laboratories (http://www.oie.int/our-scientific-expertise/reference-
laboratories/list-of-laboratories/), although strain selection for
primary and secondary H5/H7 HI antigens requires careful con-
sideration for surveillance purposes in a given region, e.g. Europe
[13]. The potential confounder of the NA subtype causing HA
cross-reactivity has been long known [32], hence the importance
of confirmatory secondary HI testing with the same HA subtype
but different NA subtype [13, 22]. False-positive results by the
H5/H7 primary HI were excluded in the sera tested in this
study by virtue of confirmation by the secondary H5/H7 HI test-
ing, and contributed to the high specificity for primary H5/H7
HI. Although it was not possible to entirely exclude the possibility
that the poultry flocks may have been seropositive due to earlier
infection by a different LPAIV subtype, the model assumed that
chickens in the 11 H5/H7 LPAIV-infected flocks had been
exposed to only these HA subtypes. This assumption was substan-
tiated by confirmation of all 11 H5/H7-infected flocks as being
H5/H7 seropositive by the secondary HI testing. Hence, there
was no evidence of prior infection with different HA subtypes
that also possessed the N3 or N7 subtypes. The assumption was
considered reasonable in view of the high standard of biosecurity
in the European commercial poultry sector, in particular chickens,
which remains apparent from the annual results of the EU
national poultry surveillance programme [18, 19].
The model estimate of ELISA specificity refers to the probabil-
ity of an AI seronegative bird testing positive. However, the
objective of serosurveillance is to detect H5/H7 seropositives,
therefore the non-H5/H7-infected birds that would test positive
for ELISA (and H5/H7 HI negative) could be viewed as false posi-
tives. In this regard, the ELISA will have lower than 99.8% speci-
ficity to detect H5/H7 infections. The probability of non-H5/H7
infected birds testing positive for ELISA will depend upon the
prevalence of non-H5/H7 strains in the epidemiological setting
where the ELISA is applied: any cost-benefit of simpler ELISA
screening may be compromised by excessive subsequent H5/H7
HI testing to exclude many infections due to non-H5/H7 AIVs.
Despite the established use of H5/H7 HI in AI laboratories, there
are concerns, which reflect the well-known antigenic variability
(drift) within a given HA subtype [33, 34]. Such intra-subtype vari-
ation may compromise the sensitivity of the primary H5/H7 HI
antigens at the screening stage. Considerable variability in the sensi-
tivity of HI relative to the ELISA was observed between flocks, as
illustrated by the over/underestimation of HI positives by the
model compared with the numbers which were observed (Fig. 1
and Table 2). Reduced sensitivity in some flocks may be caused
by a compromised immunogenic fit between the primary H5/H7
HI antigens and the antibody response elicited by the HA of the
particular H5 or H7 AIV strains responsible for infection in
these flocks. Relatively high sensitivity could imply a stronger
HI antigen–antibody relationship. Consequently, the use of an
ELISA, which detects humoral responses to the more conserved
NP antigen, was considered as an alternative to screening by primary
H5/H7 HI. These ELISA reactor flocks require subsequent primary
H5/H7 HI testing to identify LPAIV infection with these subtypes.
The heterologous H5/H7 HI antigens selected for surveillance in
the EU have been chosen on the basis of broad antigenic reactivity
to the corresponding subtypes known to be circulating in Europe
during preceding years [13]. However, mandatory poultry surveil-
lance has led to the direct discovery of an ongoing LPAIV outbreak
in only a minority of H5/H7 seropositive flocks. For example, dur-
ing 2015 serological surveillance was done in 21 867 flocks (all
poultry species) in the 28 EU MSs, revealing 33 and seven H5
and H7 seropositive holdings, respectively [19]. These 40 flocks
included only eight and three premises where active outbreaks of
H5 and H7 LPAIV respectively were occurring, as proven by
Table 4. Sample size estimates per flock.
Serological test
Within-flock prevalence (%)
2.5 5 10 20 30 40 50
Primary H5/H7 HI 235 127 66 33 22 16 13
ELISA 113 58 29 14 9 7 5
The number of samples required to detect H5/H7 seropositive chickens with a 95% probability for a range of values of within-flock seroprevalence.
Fig. 2. Distribution of the seroprevalence estimates for the 21 AI seropositive flocks
from The Netherlands, Denmark and Sweden. Estimates were derived from the appli-
cation of the Bayesian model to the data obtained from the testing of all chicken
flocks by primary HI and ELISA in the study. The actually observed seroprevalences
determined by the two tests are listed in Table 2.
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virological investigations. Successful VI provides the homologous
HI antigen for any subsequent LPAIV outbreak-related surveil-
lance, but this is not achieved for the majority of H5/H7 seroposi-
tive premises. Resolution of the LPAIV incursion and its
immunological clearance is the likely explanation in many H5/
H7 seropositive flocks.
The availability of blocking ELISAs for detection of type-
common AIV antibodies offers benefits for rapid high-throughput
screening of poultry flocks. This study showed that the blocking
ELISA clearly has superior sensitivity compared with primary
H5/H7 HI as the initial screening method for H5/H7 surveillance
in commercial chickens. Testing of 102 commercial layer farms
(1820 chicken sera) in New Zealand by an indirect ELISA identi-
fied 24 AIV seropositive flocks, with only three free-range farms
each including a single reactor serum that was H5 HI positive
[35]. It was noted that 19 of the 21 AIV seropositive flocks
detected by ELISA were free-range layers (Table 2). The blocking
ELISA used in the current study has an additional advantage in
that it is not dependent on an anti-species conjugate which is a
feature of indirect ELISAs, therefore the blocking ELISA may be
used to similarly test sera from other poultry species.
Another study has used a Bayesian version of latent class ana-
lysis to review and analyse previously published data to compare
HI and four different in-house ELISAs. It concluded that HI had a
higher diagnostic sensitivity [36]. However, that study used a dif-
ferent methodology where sera were drawn from the field- and
experimentally infected chickens during the acute post-infection
stage and used the homologous (or a near homologous) HI anti-
gen. This resulted in the HI having higher diagnostic sensitivity
than the ELISAs [36]. HI testing with the homologous H5/H7
antigens did not feature in our study, this reflecting the com-
monly encountered scenario whereby few H5/H7 seropositive
flocks identified by EU poultry surveillance successfully yield
the homologous antigen through VI. Use of the heterologous
EU-recommended H5/H7 HI antigens potentially reduced the
sensitivity of the HI testing because of the unknown degree of
immunogenic diversity within the H5/H7 subtypes.
Temporal effects may also influence the results of antibody test-
ing. It is accepted that any test for AIV antibody may remain poten-
tially vulnerable to false negative results if the collection of sera is
confined to a very early window prior to seroconversion. H7
LPAIV chicken infection studies showed seroconversion to occur
between 1 and 2 weeks post-infection (e.g. [37]). These results were
obtained by using another anti-NP blocking ELISA, with accom-
panying homologous H7 HI being more sensitive than the heterol-
ogous surveillance H7 HI antigens employed in the current study.
In an H5/H7 LPAIV field setting, however, not all chickens would
be at the same stage of infection,with somebirds already seroconvert-
ing while others are at the earlier stage of initial viral shedding. In the
event of any detectable seropositivity, the EU recommends a prompt
epidemiological investigation to include follow-up sampling of
poultry to include swabs for virological investigation plus subsequent
sera to identify any seroprevalence increase during acute stage sero-
conversion [13]. Relatively little is known concerning the decline of
AIV antibodies in experimentally infected chickens at later time
points, although one study used homologous H7 HI to demonstrate
a decline in HI titres 8 weeks post-infection [38]. To our knowledge,
there is nopublishedprolonged chicken infection studywhich specif-
ically used an anti-NP blocking ELISA. However, it is also possible
that lower seroprevalences such as those observed in six flocks in
the range 10–48.3% (by ELISA, Table 2) may be due to the LPAIV
infection not spreading efficiently within the flock.
Current EU guidelines recommend the collection of 10 sera
per chicken or turkey flock for H5/H7 AIV serosurveillance,
and this would be a sufficient sample size to provide 95% confi-
dence of detecting infection if it is present at the design seropreva-
lence of 30% [13], if initial screening is done by the blocking
ELISA (Table 4). AI seroprevalence of greater or equal to 30%
was observed in 17 of the 21 AI-infected flocks (Table 2), so it
is possible that at least some of the lower seroprevalence flocks
would have been undetected by sampling 10 sera for testing by
blocking ELISA. Again, these may represent inefficient intra-flock
LPAIV spread or historical LPAIV infections with declining sero-
prevalence and no active shedding at the time of chicken sam-
pling. Such a historical infection scenario may have occurred at
three H5 seropositive layer farms, which were identified in New
Zealand at a low seroprevalence (1/10) following type-common
ELISA screening and HI confirmation. Follow-up AIV RRT–
PCR investigations excluded any ongoing outbreaks [35].
In conclusion, the greater sensitivity of the blocking ELISA has
clearly demonstrated its preferred use for screening during sero-
logical surveillance for H5/H7 infection in EU commercial chick-
ens. Serological surveillance is therefore not applied primarily as
an early warning system for direct detection of ongoing AIV out-
breaks in individual flocks, but provides evidence for prior expos-
ure and circulating AIV within poultry populations from different
geographical regions, poultry species and management types.
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